Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

Supply of Construction Services for the Cell Therapy Catapult Manufacturing Centre.

  • First published: 15 October 2015
  • Last modified: 15 October 2015
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
Cell & Gene Therapy Catapult
Authority ID:
AA58950
Publication date:
15 October 2015
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

The Cell Therapy Catapult has received government funding to establish a large-scale Cell Therapy Manufacturing Centre in the UK. Currently, UK manufacturing is currently served by mainly small academic centres that are designed to provide material for early stage clinical trials. There is currently no large-scale infrastructure in the UK that would enable the manufacture of cell therapies for late stage, Phase III manufacturing and subsequently for in-market supply.

The lack of suitable capacity will be both an obstacle to the development of the industry and is a key gap in the infrastructure that will allow long-term value to be captured for the UK.

The large-scale Cell Therapy Manufacturing Centre will ensure the availability of manufacturing capacity in the UK for the supply of Phase III clinical trial material and ultimately enable in-market supply. It will be the model for future expansion of the Cell Therapy Manufacturing industry and form the critical mass that will enable the development of the UK industry and make the UK, the go to place for manufacturing in Europe.

The design for the Manufacturing Centre is still being developed but is likely to be in the order of 7 500 m2 and include Grade B Clean Rooms, manufacturing support and administration space.

Full notice text

CONTRACT AWARD NOTICE – OFFICIAL JOURNAL

Section I: Contracting Authority

I.1)

Name, Address and Contact Point(s)


Cell Therapy Catapult

12th Floor, Guy's Tower, Great Maze Pond

London

SE1 9RT

UK

Lisa Slade


ojeu@ct.catapult.org.uk


http://catapult.org.uk/celltherapy


I.2)

Type of contracting Authority and Main Activity or Activities

Checked box

partially funded through another contracting authority

Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Checked box

cell therapies

No

Section II: Object of the Contract

II.1)

Description

II.1.1)

Title attributed to the contract by the contracting authority

Supply of Construction Services for the Cell Therapy Catapult Manufacturing Centre.

II.1.2(a))

Type of works contract

II.1.2(b))

Type of supplies contract

II.1.2(c))

Type of service contract

II.1.2)

Main site or location of works, place of delivery or performance

Stevenage.


UKH2

II.1.3)

This notice involves a framework agreement

Unchecked box
Unchecked box

II.1.4)

Short description of the contract or purchase(s)

The Cell Therapy Catapult has received government funding to establish a large-scale Cell Therapy Manufacturing Centre in the UK. Currently, UK manufacturing is currently served by mainly small academic centres that are designed to provide material for early stage clinical trials. There is currently no large-scale infrastructure in the UK that would enable the manufacture of cell therapies for late stage, Phase III manufacturing and subsequently for in-market supply.

The lack of suitable capacity will be both an obstacle to the development of the industry and is a key gap in the infrastructure that will allow long-term value to be captured for the UK.

The large-scale Cell Therapy Manufacturing Centre will ensure the availability of manufacturing capacity in the UK for the supply of Phase III clinical trial material and ultimately enable in-market supply. It will be the model for future expansion of the Cell Therapy Manufacturing industry and form the critical mass that will enable the development of the UK industry and make the UK, the go to place for manufacturing in Europe.

The design for the Manufacturing Centre is still being developed but is likely to be in the order of 7 500 m2 and include Grade B Clean Rooms, manufacturing support and administration space.

II.1.5)

Common Procurement Vocabulary (CPV)

45000000
45214610

II.1.6)

Contract covered by the government procurement agreement (GPA)

No

II.2)

Total final value of the contract(s)

II.2.1)

Total final value of the contract(s)

   

Section IV: Procedure

IV.1)

Type of procedure

IV.1.1)

Type of procedure

IV.2)

Award criteria

IV.2.1)

Award criteria

Unchecked box
Checked box
Technical 60
Price 40

IV.2.2)

An electronic auction has been used

No

IV.3)

Administrative information

IV.3.1)

File reference number attributed by the contracting authority

CON-0058

IV.3.2)

Previous publication(s) concerning the same contract


2015/S 29-048151 11-02-2015


2015/S 38-064262 24-02-2015

Other previous publications

Section V: Award of contract

V.1)

Date of contract award:

 02-09-2015

V.2)

Numbers of offers received:

4

V.3)

Name and address of economic operator to whom the contract has been awarded


M+W High Tech Projects Ltd


Chippenham

SN14 0GT

UK




V.4)

Information on value of contract

V.5)

The contract is likely to be subcontracted

Yes

Short description of the value/proportion of the contract to be subcontracted

Section VI: Complementary Information

VI.1)

Contract related to a project and/or programme financed by community funds?

No



VI.2)

Additional Information

VI.3)

Procedures for appeal

VI.3.1)

Body responsible for appeal procedures


Cell Therapy Catapult


London

SE1 9RT


ojeu@ct.catapult.org.uk



Body responsible for mediation procedures










VI.3.2)

Lodging of appeals

VI.3.3)

Service from which information about the lodging of appeals may be obtained










VI.4)

Dispatch date of this Notice

 12-10-2015

Coding

Commodity categories

ID Title Parent category
45000000 Construction work Construction and Real Estate
45214610 Laboratory building construction work Construction work for buildings relating to education and research

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
ojeu@ct.catapult.org.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.